Development and validation of a low cost blood filtration element separating plasma from undiluted whole blood

Clinical point of care testing often needs plasma instead of whole blood. As centrifugation is labor intensive and not always accessible, filtration is a more appropriate separation technique. The complexity of whole blood is such that there is still no commercially available filtration system capable of separating small sample volumes (10-100 mu l) at the point of care. The microfluidics research in blood filtration is very active but to date nobody has validated a low cost device that simultaneously filtrates small samples of whole blood and reproducibly recovers clinically relevant biomarkers, and all this in a limited amount of time with undiluted raw samples. In this paper, we show first that plasma filtration from undiluted whole blood is feasible and reproducible in a low-cost microfluidic device. This novel microfluidic blood filtration element (BFE) extracts 12 mu l of plasma from 100 mu l of whole blood in less than 10 min. Then, we demonstrate that our device is valid for clinical studies by measuring the adsorption of interleukins through our system. This adsorption is reproducible for interleukins IL6, IL8, and IL10 but not for TNF alpha. Hence, our BFE is valid for clinical diagnostics with simple calibration prior to performing any measurement. (C) 2012 American Institute of Physics. [doi:10.1063/1.3672188]

Published in:
Biomicrofluidics, 6, 1, 012804
American Institute of Physics

 Record created 2012-03-20, last modified 2018-03-17

Rate this document:

Rate this document:
(Not yet reviewed)